Skip to main content
Equibles

Frederick E. Pierce

Board Member

Decoy Therapeutics Inc. (DCOY)

CEO

Decoy Therapeutics Inc. (DCOY)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Frederick E. Pierce

Frederick E. Pierce is recorded as Board Member and CEO at Decoy Therapeutics Inc. (DCOY). Decoy Therapeutics Inc. reported in an 8-K filed November 19, 2025 that Frederick E. Pierce was appointed Chief Executive Officer. Decoy Therapeutics Inc. reported in an 8-K filed November 13, 2025 that Frederick E. Pierce was appointed Chief Executive Officer, effective November 12, 2025. Decoy Therapeutics Inc. reported in an 8-K filed November 13, 2025 that Frederick E. Pierce was appointed Class II director, effective November 12, 2025.

“On November 18, 2025, the Company and each of Mr. Frederick E. Pierce, Dr. Barbara Hibner and Mr. Peter Marschel entered into employment agreements (the “Employment Agreements”) to serve as Chief Executive Officer, Chief Scientific Officer, and Chief Business Officer, respectively (collectively, the “Executive Officers”).”
Decoy Therapeutics Inc. Form 8-K, filed November 19, 2025 · Read the filing
“Also on November 12, 2025, the Company appointed Mr. Pierce as Chief Executive Officer, Dr. Barbara Hibner as Chief Scientific Officer, and Mr. Peter Marschel as Chief Business Officer.”
Decoy Therapeutics Inc. Form 8-K, filed November 13, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Decoy Therapeutics Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.